3-O-[beta-D-glucopyranosyl(1→2)]-[alpha-L-arabinopyranosyl(1→3)]-[alpha-L-arabinofuranosyl(1→4)]-beta-D-glucuronopyranosyl-21-(2-acetoxy-2-methylbutanoyl)-22-acetylbarrigenol - Compound Card

3-O-[beta-D-glucopyranosyl(1→2)]-[alpha-L-arabinopyranosyl(1→3)]-[alpha-L-arabinofuranosyl(1→4)]-beta-D-glucuronopyranosyl-21-(2-acetoxy-2-methylbutanoyl)-22-acetylbarrigenol

Select a section from the left sidebar

3-O-[beta-D-glucopyranosyl(1→2)]-[alpha-L-arabinopyranosyl(1→3)]-[alpha-L-arabinofuranosyl(1→4)]-beta-D-glucuronopyranosyl-21-(2-acetoxy-2-methylbutanoyl)-22-acetylbarrigenol

Structure
Zoomed Structure
  • Family: Plantae - Pittosporaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Triterpenoid
Canonical Smiles OCC1O[C@@H](OC2[C@@H](OC([C@H]([C@@H]2O[C@@H]2OC[C@@H]([C@@H](C2O)O)O)O[C@H]2C[C@@H]([C@@H](O2)CO)O)C(=O)O)O[C@H]2CC[C@]3(C(C2(C)C)CC[C@@]2(C3CC=C3[C@@]2(C)[C@@H](O)[C@H]([C@@]2(C3CC(C)(C)C(C2OC(=O)C)OC(=O)C(OC(=O)C)(CC)C)CO)O)C)C)C([C@H]([C@@H]1O)O)O
InChI InChI=1S/C61H96O28/c1-12-59(10,89-26(3)66)54(78)88-48-49(80-25(2)65)61(24-64)28(20-55(48,4)5)27-13-14-34-57(8)17-16-35(56(6,7)33(57)15-18-58(34,9)60(27,11)46(74)47(61)75)83-53-45(87-52-41(73)39(71)38(70)32(22-63)82-52)43(85-51-40(72)37(69)30(68)23-79-51)42(44(86-53)50(76)77)84-36-19-29(67)31(21-62)81-36/h13,28-49,51-53,62-64,67-75H,12,14-24H2,1-11H3,(H,76,77)/t28?,29-,30-,31-,32?,33?,34?,35-,36-,37-,38+,39-,40?,41?,42-,43-,44?,45?,46-,47+,48?,49?,51-,52-,53+,57-,58+,59?,60-,61-/m0/s1
InChIKey BISOBRHAPNCOEH-RPHUVRFHSA-N
Formula C61H96O28
HBA 27
HBD 13
MW 1277.41
Rotatable Bonds 17
TPSA 432.8
LogP -1.43
Number Rings 9
Number Aromatic Rings 0
Heavy Atom Count 89
Formal Charge 0
Fraction CSP3 0.9
Exact Mass 1276.61
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Pittosporum tobira Pittosporaceae Plantae 43073

Showing of synonyms

  • El Dib R.A, Eskander J, et al. (2015). Two new triterpenoid estersaponins and biological activities of Pittosporum tobira ‘Variegata’ (Thunb.) W. T. Aiton leaves. Fitoterapia, 2015, 106, 272-9. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: O1CCCC1OC2COC(C(OC3CCCCO3)C2OC4CCCCO4)OC(CC5)CC(CC6)C5C(CC7)C6C(C=78)CCC9C8CCCC9

Level: 4

Mol. Weight: 1277.41 g/mol

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CC(CC5)OC6OCCC(OC7CCCCO7)C6OC8CCCCO8

Level: 3

Mol. Weight: 1277.41 g/mol

Structure

SMILES: O1CCCCC1OC2C(OC3CCCO3)COC(C2)OC(CC4)CC(CC5)C4C(CC6)C5C(C=67)CCC8C7CCCC8

Level: 3

Mol. Weight: 1277.41 g/mol

Structure

SMILES: O1CCCC1OC(C2)COC(C2OC3CCCCO3)OC(CC4)CC(CC5)C4C(CC6)C5C(C=67)CCC8C7CCCC8

Level: 3

Mol. Weight: 1277.41 g/mol

Structure

SMILES: O1CCCCC1OC2C(OC3CCCO3)COCC2OC4CCCCO4

Level: 3

Mol. Weight: 1277.41 g/mol

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CC(CC5)OC(OCCC6)C6OC7CCCCO7

Level: 2

Mol. Weight: 1277.41 g/mol

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CC(CC5)OC(OCC6)CC6OC7CCCCO7

Level: 2

Mol. Weight: 1277.41 g/mol

Structure

SMILES: O1CCCC1OC2CCC(OC2)OC(CC3)CC(CC4)C3C(CC5)C4C(C=56)CCC7C6CCCC7

Level: 2

Mol. Weight: 1277.41 g/mol

Structure

SMILES: O1CCCCC1OC2C(COCC2)OC3CCCCO3

Level: 2

Mol. Weight: 1277.41 g/mol

Structure

SMILES: O1CCCC1OC2CC(COC2)OC3CCCCO3

Level: 2

Mol. Weight: 1277.41 g/mol

Structure

SMILES: O1CCCC1OC(COCC2)C2OC3CCCCO3

Level: 2

Mol. Weight: 1277.41 g/mol

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CC(CC5)OC6CCCCO6

Level: 1

Mol. Weight: 1277.41 g/mol

Structure

SMILES: C1OCCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1277.41 g/mol

Structure

SMILES: C1COCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1277.41 g/mol

Structure

SMILES: O1CCCC1OC2CCCOC2

Level: 1

Mol. Weight: 1277.41 g/mol

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CCCC5

Level: 0

Mol. Weight: 1277.41 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 1277.41 g/mol

Structure

SMILES: C1CCOC1

Level: 0

Mol. Weight: 1277.41 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-6.5
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
743477217943.45
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
97163653126615.34

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.73
Plasma Protein Binding
53.84
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Inhibitor
OATP1B3
Inhibitor

Excretion

Clearance
1.86
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Toxic
Bee
Safe
Bioconcentration Factor
-2259806510262.69
Biodegradation
Toxic
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-922706.13
Liver Injury II
Toxic
hERG Blockers
Toxic
Daphnia Maga
4.05
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-176347349235136400
Rat (Acute)
72.8
Rat (Chronic Oral)
378249732.7
Fathead Minnow
222601016846326.62
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
19834191040483690
Hydration Free Energy
-2.92
Log(D) at pH=7.4
-11025829942.19
Log(P)
-1283535.98
Log S
-2.21
Log(Vapor Pressure)
-653129863236022.5
Melting Point
-198459331.15
pKa Acid
-4759079702002.19
pKa Basic
-38286666854.14
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Nuclear receptor subfamily 5 group A member 2 O00482 NR5A2_HUMAN Homo sapiens 4 0.7226

Download SDF